Novo Nordisk expects price pressure on obesity drugs from "a competitor"
CFO Karsten Munk Knudsen could barely bring himself to say the name.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.